Evotec SE (ETR:EVT – Get Free Report)’s share price traded down 1.3% on Thursday . The company traded as low as €6.30 ($6.84) and last traded at €6.32 ($6.86). 509,397 shares were traded during mid-day trading, a decline of 63% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.40 ($6.95).
Evotec Stock Performance
The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -6.49, a P/E/G ratio of 0.98 and a beta of 1.05. The company has a 50 day moving average price of €7.72 and a two-hundred day moving average price of €7.64.
Evotec Company Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Further Reading
- Five stocks we like better than Evotec
- What to Know About Investing in Penny Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- Retail Stocks Investing, Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
